Form D · Pharmaceuticals

Lomond Therapeutics Holdings, Inc.

Dover, DE · CIK 0001900520

Offering snapshot reported Feb 11, 2025 · SEC filing

Reported sold
$53.9M
Offering amount: $63.9M
Investors reported
28
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 1, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$27M$53.9MNov 18, 2024: $43,900,000.00Nov 18, 2024Feb 11, 2025: $53,915,492.00Feb 11, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$43,900,000 → $53,915,492
  • Reported investors27 → 28

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 11, 2025Amendment$53,915,492$10,015,492vs Nov 18, 202428SEC filing
Nov 18, 2024Initial$43,900,000No comparison27SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
Yes
Sales commissions
$3.11M
Finders' fees
$0
Form D file number
021-529644
Total Amount Sold includes the conversion of SAFEs with an aggregate value of $10,949,992.
In addition to Sales Commissions, warrants to purchase an aggregate of 275,410 shares of the Issuer's Common Stock wereissued to the placement agents.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Raymond James & Associates, Inc.000000705
Wedbush & Co., LLC000328492

Source: Form D, filed Feb 11, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Iain Dukes Director, Executive
Carl Gordon Director
Eddie Rodriguez Director
Nikolay Savchuk Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
8 The Green, Suite 8490
Dover, DE, 19901